| Tag | Content |
|---|
EnhancerAtlas ID | HS060-22904 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr22:22521100-22523340 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXP1 | MA0481.2 | chr22:22523177-22523189 | AGGTAAACAGAA | + | 6.14 | | IRF1 | MA0050.2 | chr22:22522714-22522735 | TGTCTGTTTCGGTTTCAGTAT | + | 6.12 | | IRF8 | MA0652.1 | chr22:22522718-22522732 | TGTTTCGGTTTCAG | - | 6.51 | | IRF9 | MA0653.1 | chr22:22522718-22522733 | TGTTTCGGTTTCAGT | - | 6.28 | | MLX | MA0663.1 | chr22:22523099-22523109 | ATCACGTGAT | + | 6.02 | | MLX | MA0663.1 | chr22:22523099-22523109 | ATCACGTGAT | - | 6.02 | | MLXIPL | MA0664.1 | chr22:22523099-22523109 | ATCACGTGAT | + | 6.02 | | MLXIPL | MA0664.1 | chr22:22523099-22523109 | ATCACGTGAT | - | 6.02 | | NKX2-5 | MA0063.2 | chr22:22522367-22522377 | CTCAAGTGGT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10412 | chr22:22515989-22524255 | CD19_Primary | | SE_11755 | chr22:22515924-22526610 | CD20 | | SE_43941 | chr22:22519587-22524246 | MM1S | | SE_58581 | chr22:22508304-22574865 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I022165 | chr22 | 22519427 | 22523670 |
|
Enhancer Sequence | AGGCTGTGGT GCCTCAGAAA CCCTCCTAGT CAACAACACC CTGCCCAGCA GGAGCGGGCC 60
ATGCTCTGAT TGCCCATCTG GGGTAGTGTC AGTGGGGCTC AGTGAGCAGC TGAGCTTTCA 120
CCCCAATATC CTCAACCAGG CGAGCATGGC AGGGCTAGTT TGAGCTGGTT TATCCTCCCA 180
TCCACCTATG CCTGATTTTG GCAGGGCCCA GTCAGGAACT GAATTTCAGC CCCCATCCCC 240
AGCAATGAGT TGAATGAAAT GGTACAAGGC AGAGCACACC AGCCCTCAGT ATTCCCTCCC 300
TGAACCCAGA CTCTGGTGGT TATGGGGGCC AGGGAGGACC AGAGCTTTGT CTCCCACCTG 360
GCAATGAGAA TACTGGTTGG GGATGGAAGT CAGTGTCGTT GGCACACCTG CTGTCCCCCT 420
CCCTGCCCTG GTGTCAGTGA GTCCTCTTTT TCTCATGAAA GTGTCAGCAG CACTGGAGTA 480
CTGAGAGCCA GCGTTCTGCC TTTGCTTTGG CAGTGGGAAG CTGAACCTAC AAACCTGTGT 540
CCTTCAACAA CTCAACAAGA AGATCACCTG ATAAAAGGGA GATTAGTGGT GCCTAGAGGC 600
TCAAAATACA GTATTTAAGG TGTCTAGCAT TCAGTTCATG AAATCATTGT CACATCAAGA 660
ATTAGGACAT TCAGAACCCA AATGAAAGAA GACAGTGACA CGCATGGACA CTGAAGCAAA 720
CTCAGATGCT AAAATCATAT GACGGATTTT TAAAGCAACA ACCACAAAAT CCCTTCAATG 780
AATAATTAAA AACACTCTTG AAACAAATGG AAAAGAAGAA AATCTCAGAA AAGAGAAGTT 840
ATAAAATCAA ACCAACTGGA AATTAAAGAA CCTAATAAAC TAGAGCACAT TTAAAAAGAA 900
AGTTAAGGCA GGACTCAAGA ACTGGTTACA TTTGAGATTC AGTCACTGGG TGAGGTGTTC 960
CACACGACAT AAAAATACAG TAAAAATAAG TAGGTAAACA CATGAAAATC AATGATTCTG 1020
GTTTGACTTG GGAAACATTA AAGTGGAAAA TATAAAGAAT AAAATAGCAT TTATTTATTG 1080
AAAGAAAGAA CTACCTTTAG CTTTTTATCG TTTCCCCATT AATACTCTCT TGAAGATGTT 1140
CCCAGGGGAC ACTGTGAGTC TTCTCAGAGG TGAGAAAAGC CTGAAATAAA CTCCCACGAA 1200
TCTCATTTAA TGGGTCCTGG GGCCCATGCT CACTGGTCTG AGTTAGAGGT GATAGCAGGT 1260
GCTTCCTCTC AAGTGGTGAA ATTAGACCTC ACAGCAGCCC AGCCCCCCTG ACAGTAGAGC 1320
TGCTCTCTCA GCTGAAAACA ACAGAAGCAG ATGGTGTTGG TGATGGTTTT GGTAAAGTGC 1380
TTATTAATGT GTGAACCAAA TATATGCCCT TCATCTAGGG AGCTGCATAG GAGATAAAAG 1440
AACCATCTCA GGGTCCAGCA GCATCTTAGA GCTCTGCAGA TTTTTGGAAA GTTTACATCA 1500
TGCCCTGGAT GCTTCTCCTC CACTTCCCCA TCCTGTTCAG TCTTTGCCCA GGTTCATGGA 1560
GATTTCAAAG ACCAGCCCAT GGAGAGAGCC CTCTGTTCTT CCCCATTCCT GTCGTGTCTG 1620
TTTCGGTTTC AGTATCCAGT TCTTAGGGTG TGGTGACTGA GGAGCCCTCA CTGACTCTTT 1680
CCTGAGGAGG GACAGTCACT CTCACCTGTG GCTCCAGCAC CAGAGTGGTC ACCAACAATT 1740
TCTATCCACA CTGGATGCAA CAGAAGTCTG GCCAACTTTT TGAGACATTG ATTTATGATG 1800
CAAGCAACAA ACATTCCTGA ATGACCACCT GATTCTCAGA CCTTCCTGGG AGCAAAGCTG 1860
CCCTGAGCCT CTGGGGGACC CAATCCATAG GCTAGACTGA GTACTACTCA AGCTACACGA 1920
CAGTGGGGGT TACTGCAGTG AAAGATCCAG ATGGGGAGCC AAGACGTAAC CCTGCCTCTG 1980
ACAGCCTGGG GAGAAAATGA TCACGTGATA TCAGGATCAC ATGACCAGAA ACCTGAGCTC 2040
TCAAGGCGGT CTAAATGTTG CCTATCCTTA AAGAAAAAGG TAAACAGAAG GGTCTACATC 2100
AATATTTATT CCTGTTTGTG TCCAAAAGTT GAGGAAATCC ATCAATGAGG AGGAACTGTT 2160
CCAGAAAAGC GGATTCCTAA TATTTTGTAA TCCAAAAGGA ATAGTATTGC CTACATCAGA 2220
TCCAAGGAAT AAATTTAAAT 2240
|
